During the past decade, Hamamatsu University School of Medicine conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hamamatsu University School of Medicine" #1 sponsor was "Hamamatsu University" with 17 trials, followed by "AO Foundation, AO Spine" with 4 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 4 trials sponsored, "Haruhiko Fukuda" with 2 trials sponsored and "Merck Sharp & Dohme LLC" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hamamatsu University School of Medicine" #1 collaborator was "Eisai Inc." with 2 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 2 trials as a collaborator, "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator, "Scoliosis Research Society" with 2 trials as a collaborator and "Tokyo Medical and Dental University" with 2 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Hamamatsu University School of Medicine" are "Gastric Ulcer" (4 trials), "Adult Spinal Deformity" (3 trials), "Colorectal Cancer" (3 trials), "Duodenal Ulcer" (3 trials) and "H. Pylori Infection" (3 trials). Many other conditions were trialed in "Hamamatsu University School of Medicine" in a lesser frequency.

Most popular intervention types in "Hamamatsu University School of Medicine" are "Drug" (26 trials), "Procedure" (8 trials), "Biological" (2 trials), "Other" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Belzutifan" (2 trials), "Lenvatinib" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "velaglucerase alfa" (2 trials) and "Amoxicillin 500 mg tid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hamamatsu University School of Medicine" are 35 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Hamamatsu University School of Medicine". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Hamamatsu University School of Medicine, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hamamatsu University School of Medicine, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".